Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
Serogroup C meningococcal conjugate vaccines, first launched in the UK in 1999, have been used successfully in Australia, Canada and several other European countries. Combination conjugate vaccines, containing more than one meningococcal polysaccharide, have been developed to broaden protection against the disease. A tetravalent meningococcal A, C, Y and W-135 conjugate vaccine was licensed for use in 11-55 year old adolescents and adults in the US in January 2005, and subsequently also in 2-...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- BMJ Publishing Group Ltd Publisher's website
- Archives of disease in childhood Journal website
- Publication date:
- Source identifiers:
- Local pid:
- Copyright holder:
- BMJ Publishing Group Ltd
- Copyright date:
- The full-text of this article is not currently available in ORA, but you may be able to access the article via the publisher copy link on this record page.